Two new drugs added to WHO list of COVID-19 therapies
pharmaphorum
JANUARY 17, 2022
The drug, developed by Incyte and licenced to Lilly, is also used to treat rheumatoid arthritis. It prevents the overstimulation of the immune system and is said to improve survival and reduce the need for ventilation in covid-19 patients, with no observed increase in adverse effects.
Let's personalize your content